Skye Bioscience, Inc. Debt Conversion, Converted Instrument, Amount
Skye Bioscience, Inc. (SKYE) reported Debt Conversion, Converted Instrument, Amount of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2026-03-10
- Skye Bioscience, Inc. debt conversion, converted instrument, amount for the quarter ending 2018-12-31 was $3.77K.
- Skye Bioscience, Inc. debt conversion, converted instrument, amount for the quarter ending 2018-09-30 was $0.00.
- Skye Bioscience, Inc. debt conversion, converted instrument, amount for the quarter ending 2018-06-30 was $0.00.
- Skye Bioscience, Inc. debt conversion, converted instrument, amount for the quarter ending 2018-03-31 was $1.71M.
- Skye Bioscience, Inc. debt conversion, converted instrument, amount for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Skye Bioscience, Inc. debt conversion, converted instrument, amount for fiscal 2024 was $4.97M.
- Skye Bioscience, Inc. debt conversion, converted instrument, amount for fiscal 2018 was $1.71M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-10 | |||
| 2024-12-31 | $4.97M 10-K · filed 2026-03-10 | |||
| 2018-12-31 | $3.77K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $3.77K derived: sum of 2 quarters · filed 2020-03-23 | $3.77K derived: sum of 3 quarters · filed 2020-03-23 | $1.71M 10-K · filed 2020-03-23 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $1.71M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.71M 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $1.71M 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |